The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sanna Bastiano since 2021.
This trader's CIK number is 1829069.
At the time of last reporting, Sanna Bastiano was the EVP, Cell & Genetic Therapies of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | VRTX | 0 | $0 | 20,797 | $6,844,292 | 0 | $0 |
| 2022 | VRTX | 0 | $0 | 9,640 | $2,612,748 | 0 | $0 |
| 2021 | VRTX | 0 | $0 | 4,332 | $926,871 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-05 | VRTX | Sale | 422 | 350.03 | 147,712 |
| 2023-05-08 | VRTX | Sale | 2,850 | 350.00 | 997,500 |
| 2023-05-02 | VRTX | Sale | 1,622 | 351.74 | 570,517 |
| 2023-05-03 | VRTX | Sale | 2,781 | 351.02 | 976,186 |
| 2023-04-12 | VRTX | Sale | 7,567 | 326.53 | 2,470,829 |
| 2023-04-04 | VRTX | Sale | 522 | 316.59 | 165,262 |
| 2023-03-16 | VRTX | Sale | 2,746 | 300.81 | 826,010 |
| 2023-02-14 | VRTX | Sale | 2,181 | 300.70 | 655,826 |
| 2023-01-31 | VRTX | Sale | 106 | 325.00 | 34,450 |
| 2022-10-18 | VRTX | Sale | 1,791 | 300.93 | 538,965 |
| 2022-05-16 | VRTX | Sale | 45 | 252.56 | 11,365 |
| 2022-05-04 | VRTX | Sale | 36 | 275.09 | 9,903 |
| 2022-05-02 | VRTX | Sale | 320 | 259.66 | 83,090 |
| 2022-04-07 | VRTX | Sale | 561 | 276.37 | 155,045 |
| 2022-04-04 | VRTX | Sale | 562 | 267.76 | 150,483 |
| 2022-04-05 | VRTX | Sale | 3,163 | 275.23 | 870,552 |
| 2022-03-17 | VRTX | Sale | 2,122 | 250.06 | 530,627 |
| 2022-02-02 | VRTX | Sale | 1,040 | 252.61 | 262,718 |
| 2021-05-03 | VRTX | Sale | 960 | 218.44 | 209,707 |
| 2021-04-05 | VRTX | Sale | 1,686 | 214.44 | 361,545 |
| 2021-02-11 | VRTX | Sale | 1,686 | 210.93 | 355,619 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sanna Bastiano (EVP, Cell & Genetic Therapies of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.